November 28, 2023 November 28, 2023Julius Clinical Research Receives Growth Investment from Ampersand Capital Partners
November 20, 2023 November 20, 2023New Capital Strengthens ProtaGene’s Advanced Analytical Leadership in the Biologics and Cell and Gene Therapy Markets
November 6, 2023 November 6, 2023Ampersand Capital Partners Named to Inc.’s 2023 List of Founder-Friendly Investors
November 2, 2023 November 2, 2023Genezen Secures $18.5 Million in Growth Equity to Expand Viral Vector Development and Manufacturing Capabilities
October 16, 2023 October 16, 2023P95, a leading vaccine-focused CRO, merges with South Africa-based CRO OnQ Research
September 12, 2023 September 12, 2023Sterling Medical Devices and RBC Medical Innovations Rebrand as Vantage MedTech
August 3, 2023 August 3, 2023NanoImaging Services Sets New Standards as the First cGMP Compliant Cryo-TEM Lab in North America
July 17, 2023 July 17, 2023Preqin Ranks Ampersand Capital Partners as the Top Performing Private Equity Fund Manager and Top Performing Growth Fund Manager in the Americas
